TrialBMC cardiovascular disorders2016

Safety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm; a phase 3b randomized controlled trial.

Gregory N Beatch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.